2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Rexlemestrocel-L: new trials by email Literature Review of Rexlemestrocel-L trials Research Report on Rexlemestrocel-L
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain Rexlemestrocel-L, Rexlemestrocel-L + HA Mixture, Placebo - Degenerative Disc Disease | Phase 3 | Completed | Mesoblast, Ltd. | 404 | 2015-03-06 | 2022-10-19 |
| Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure Rexlemestrocel-L, Sham Comparator - Chronic Heart Failure | Phase 3 | Completed | Mesoblast, Inc. | 565 | 2014-03-03 | 2026-03-23 |
Back Pain (1) · Bone Diseases (1) · Inflammation (1) · Intervertebral Disc Degeneration (1) · Low Back Pain (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pain (1) · Spinal Diseases (1) · Ventricular Dysfunction, Left (1)
Mesoblast, Inc. (1) · Mesoblast, Ltd. (1)
United States (2) · Australia (1) · Canada (1)
Eric Rose, MD (1) · Roger Brown (1)